Facebook Pixel Code

Shukra Pharmaceuticals Share Price

NSE
BSE

SHUKRA PHARMACEUTICALS

Smallcap | BSE

Here's the live share price of Shukra Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹31.64 Closed
-4.58₹ -1.52
As on Apr 22, 2026, 04:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Shukra Pharmaceuticals Price Performance

Today's LowToday's High
₹31.55₹33.50
₹31.64
52 Weeks' Low52 Weeks' High
₹11.74₹65.26
₹31.64
Open Price
₹33.16
Prev. Close
₹33.16
Volume
4,88,488

Shukra Pharmaceuticals Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Shukra Pharmaceuticals
-10.50-11.20-29.69-19.8867.76151.79133.59
Sun Pharmaceutical Industries
-1.40-4.942.32-1.15-6.6719.4621.13
Divi's Laboratories
-0.484.254.37-4.485.9125.2110.79
Torrent Pharmaceuticals
-1.62-2.974.1213.0422.6336.1125.98
Lupin
-1.140.127.6218.5510.1148.5216.73
Dr. Reddy's Laboratories
-0.38-2.87-1.50-4.942.588.183.19
Cipla
0.351.01-6.07-24.94-19.4711.005.51
Zydus Lifesciences
-1.197.845.22-7.926.8921.5110.94
Mankind Pharma
6.1416.206.23-8.79-12.2316.199.42
Aurobindo Pharma
2.3610.9025.2029.1013.7034.007.40
Alkem Laboratories
0.678.93-2.451.367.1417.7714.90
Glenmark Pharmaceuticals
-0.567.1713.5120.9358.5262.9831.57
Laurus Labs
-2.6214.408.1517.4369.1154.5219.40
Biocon
2.03-2.64-2.39-1.306.4916.61-2.19
Abbott India
-1.58-0.07-8.54-15.43-16.384.1611.02
Anthem Biosciences
4.5820.2524.055.223.481.150.69
GlaxoSmithKline Pharmaceuticals
2.198.436.94-10.42-13.2925.4011.15
Ipca Laboratories
2.23-2.542.1017.271.5921.867.29
Ajanta Pharma
-1.31-0.343.3815.514.0229.5018.01
J B Chemicals & Pharmaceuticals
0.07-5.137.3315.7724.6023.6524.21

Over the last one year, Shukra Pharmaceuticals has gained 67.76% compared to peers like Sun Pharmaceutical Industries (-6.67%), Divi's Laboratories (5.91%), Torrent Pharmaceuticals (22.63%). From a 5 year perspective, Shukra Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (21.13%) and Divi's Laboratories (10.79%).

Shukra Pharmaceuticals Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Shukra Pharmaceuticals Stock Technicals

Moving Average

DaySMAEMA
534.4833.4
1034.4633.84
2034.5834.72
5038.337.57
10043.2138.83
20035.9135.54

Shukra Pharmaceuticals Share Holding Pattern

In the latest quarter, Shukra Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 0.11%, FII holding unchanged at 0.00%, and public shareholding moved down to 48.92% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Shukra Pharmaceuticals Corporate Actions

Date Time
Announcement
Apr 08, 2026, 10:43 PM IST ISTShukra Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Mar 16, 2026, 07:03 PM IST ISTShukra Pharma. - Board Meeting Outcome for Independent Directors Meeting
Mar 06, 2026, 10:15 PM IST ISTShukra Pharma. - Board Meeting Intimation for Independent Directors Meeting
Feb 05, 2026, 07:43 PM IST ISTShukra Pharma. - Newspaper Publication Of Standalone And Consolidated Un-Audited Financial Results For Quarter And Nine Month
Feb 04, 2026, 09:58 PM IST ISTShukra Pharma. - Unaudited Financial Results For The Quarter Ended December 2025

About Shukra Pharmaceuticals

Shukra Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/03/1993 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ1993PLC019079 and registration number is 019079. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 32.59 Cr. and Equity Capital is Rs. 43.79 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Dakshesh Rameshchandra Shah
    Managing Director
  • Mrs. Payal Sujay Mehta
    Executive Director
  • Mr. Dhruvin Shah
    Whole Time Director
  • Mr. Sanskruti Jayeshbhai Patel
    Whole Time Director
  • Mrs. Anar Jayeshbhai Patel
    Whole Time Director
  • Mrs. Shital Shah
    Whole Time Director
  • Mrs. Bhoomiben Patel
    Independent Director
  • Mrs. Sonal Deepalbhai Gandhi
    Independent Director
  • Mr. Sarjeevan Singh Rathore
    Independent Director
  • Mr. Jitendra Somchand Shah
    Independent Director
  • Mrs. Pinki Nirmal Sagar
    Independent Director
  • Mrs. Ritu Kapoor
    Independent Director

FAQs on Shukra Pharmaceuticals Share Price

What is the share price of Shukra Pharmaceuticals?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Shukra Pharmaceuticals is ₹31.64 as on Apr 22, 2026.

What kind of stock is Shukra Pharmaceuticals?

The Shukra Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Shukra Pharmaceuticals?

The market cap of Shukra Pharmaceuticals is ₹1,385.45 Cr as on Apr 22, 2026.

What are today's High and Low prices of Shukra Pharmaceuticals?

Today’s highest and lowest price of Shukra Pharmaceuticals are ₹33.50 and ₹31.55.

What are the 52 Week High and 52 Week Low of Shukra Pharmaceuticals?

The 52-week high/low is the highest and lowest price at which Shukra Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Shukra Pharmaceuticals is ₹65.26 and 52-week low of Shukra Pharmaceuticals is ₹11.74 as on Apr 22, 2026.

How has the Shukra Pharmaceuticals performed historically in terms of returns?

The Shukra Pharmaceuticals has shown returns of -4.58% over the past day, -11.2% for the past month, -27.43% over 3 months, 63.01% over 1 year, 151.79% across 3 years, and 133.59% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Shukra Pharmaceuticals?

P/E ratio of and PB ratio of Shukra Pharmaceuticals are 47.51 and 16.08 on Apr 22, 2026. While the company gives a dividend yield of 0.03 per annum.

Shukra Pharmaceuticals News

icon
Market Pulse